SCHEMBL7717062

SCHEMBL7717062

c1cc(OCc2ccc(OCc3ccc4ccccc4n3)cc2)cc(-c2nnn[nH]2)c1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 3/20 0.59
CYSLTR1 Q9Y271 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9212940 0.94 CYSLTR1 (0.65) CYSLTR2CYSLTR1
SCHEMBL7010321 0.93 CYSLTR1 (0.60) CYSLTR2CYSLTR1
SCHEMBL7005427 0.92 CYSLTR1 (0.57) CYSLTR2CYSLTR1
SCHEMBL6088514 0.92 CYSLTR1 (0.53) CYSLTR2CYSLTR1
SCHEMBL7008709 0.91 CYSLTR1 (0.57) CYSLTR2CYSLTR1
SCHEMBL7101389 0.91 CYSLTR1 (0.57) CYSLTR2CYSLTR1
SCHEMBL7715802 0.91 CYSLTR1 (0.57) CYSLTR2CYSLTR1
SCHEMBL6089355 0.90 CYSLTR1 (0.57) CYSLTR2CYSLTR1
SCHEMBL9828161 0.89 CYSLTR1 (0.58) CYSLTR2CYSLTR1
SCHEMBL9827697 0.89 CYSLTR1 (0.56) CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376512-B1 FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-23 US disclosed
US-5059610-A QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-10-22 US disclosed
US-4920132-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed